Difference between revisions of "Streptococcus anginosus"

m (Rossdonaldson1 moved page Strep. milleri to Streptococcus anginosus)
(Background)
Line 1: Line 1:
 
==Background==
 
==Background==
 +
*Previously known as Strep milleri
  
 
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>==
 
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>==

Revision as of 06:33, 3 June 2014

Background

  • Previously known as Strep milleri

Antibiotic Sensitivities[1]

Organisms ' Strep. milleri
Penicillins Penicillin G +
Penicillin V +
Anti-Staphylocccal Penicillins Methicillin +
Nafcillin/Oxacillin +
Cloxacillin/Diclox. +
Amino-Penicillins AMP/Amox +
Amox/Clav +
AMP-Sulb +
Anti-Pseudomonal Penicillins Ticarcillin +
Ticar-Clav +
Pip-Taxo +
Carbapenems Piperacillin +
Doripenem +
Ertapenem +
Imipenem +
Meropenem +
Aztreonam 0
Fluroquinolones Ciprofloxacin 0
Ofloxacin 0
Pefloxacin
Levofloxacin +
Moxifloxacin +
Gemifloxacin +
Gatifloxacin +
1st G Cephalosporin Cefazolin
2nd G. Cephalosporin Cefotetan
Cefoxitin
Cefuroxime
3rd/4th G. Cephalosporin CefoTAXime
Cefizoxime
CefTRIAXone
Ceftobiprole
Ceftaroline
CefTAZidime
Cefepime
Oral 1st G. Cephalosporin Cefadroxil
Cephalexin
Oral 2nd G. Cephalosporin Cefaclor/Loracarbef
Cefproxil
Cefuroxime axetil
Oral 3rd G. Cephalosporin Cefixime
Ceftibuten
Cefpodox/Cefdinir/Cefditoren
Aminoglycosides Gentamicin
Tobramycin
Amikacin
Chloramphenicol
Clindamycin
Macrolides Erythromycin
Azithromycin
Clarithromycin
Ketolide Telithromycin
Tetracyclines Doxycycline
Minocycline
Glycylcycline Tigecycline
Glyco/Lipoclycopeptides Vancomycin
Teicoplanin
Telavancin
Fusidic Acid
Trimethoprim
TMP-SMX
Urinary Agents Nitrofurantoin
Fosfomycin
Other Rifampin
Metronidazole
Quinupristin dalfoppristin
Linezolid
Daptomycin
Colistimethate

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Sanford Guide to Antimicrobial Therapy 2010

Authors:

Ross Donaldson